Unnamed: 0,title,date,stock,sentiment
46345.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-08 07:50:00-04:00,AGRX,neutral
46346.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-07 07:32:00-04:00,AGRX,neutral
46347.0,66 Biggest Movers From Yesterday,2020-05-07 05:52:00-04:00,AGRX,neutral
46348.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-05-06 13:19:00-04:00,AGRX,neutral
46349.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,AGRX,positive
46350.0,Agile Therapeutics Q1 EPS $(0.100) Misses $(0.090) Estimate,2020-05-05 16:13:00-04:00,AGRX,negative
46351.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,AGRX,positive
46352.0,55 Stocks Moving In Monday's Mid-Day Session,2020-05-04 12:39:00-04:00,AGRX,neutral
46353.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-05-04 07:44:00-04:00,AGRX,neutral
46354.0,30 Stocks Moving in Monday's Pre-Market Session,2020-05-04 07:05:00-04:00,AGRX,neutral
46355.0,98 Biggest Movers From Friday,2020-05-04 05:08:00-04:00,AGRX,neutral
46356.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,AGRX,neutral
46357.0,"H.C. Wainwright Reiterates Buy on Agile Therapeutics, Lowers Price Target to $6",2020-03-20 08:08:00-04:00,AGRX,negative
46358.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,AGRX,negative
46359.0,100 Biggest Movers From Friday,2020-03-09 05:25:00-04:00,AGRX,neutral
46360.0,Agile Therapeutics Shares Spike Over $2.40 Resistance Level; Pre-Market Form 4 Filing From CFO Dennis Reilly Showed Purchase Of 75K Shares,2020-03-06 11:27:00-05:00,AGRX,positive
46361.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,AGRX,neutral
46362.0,46 Stocks Moving in Friday's Pre-Market Session,2020-02-28 07:39:00-05:00,AGRX,neutral
46363.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,AGRX,neutral
46364.0,100 Stocks Moving In Thursday's Mid-Day Session,2020-02-27 12:24:00-05:00,AGRX,neutral
46365.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,AGRX,negative
46366.0,94 Biggest Movers From Friday,2020-02-24 04:53:00-05:00,AGRX,neutral
46367.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,AGRX,neutral
46368.0,68 Stocks Moving In Friday's Mid-Day Session,2020-02-21 12:29:00-05:00,AGRX,neutral
46369.0,Agile Therapeutics shares are trading lower after the company priced a 15 million share common stock offering at $3 per share.,2020-02-21 09:16:00-05:00,AGRX,positive
46370.0,Agile Therapeutics Prices 15M Share Offering At $3/Share,2020-02-21 08:35:00-05:00,AGRX,positive
46371.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,AGRX,negative
46372.0,12 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-21 07:39:00-05:00,AGRX,neutral
46373.0,33 Stocks Moving in Friday's Pre-Market Session,2020-02-21 07:15:00-05:00,AGRX,neutral
46374.0,"8 Stocks To Watch For February 21, 2020",2020-02-21 04:55:00-05:00,AGRX,neutral
46375.0,17 Stocks Moving In Thursday's After-Hours Session,2020-02-20 17:33:00-05:00,AGRX,neutral
46376.0,Agile Therapeutics shares are trading lower after the company announced a proposed underwritten public offering of common stock. No size was disclosed.,2020-02-20 16:25:00-05:00,AGRX,negative
46377.0,"Agile Therapeutics Reports Offering Of Common Stock, No Size Disclosed",2020-02-20 16:17:00-05:00,AGRX,negative
46378.0,Agile Therapeutics Q4 EPS $(0.1) Up From $(0.11) YoY,2020-02-20 16:02:00-05:00,AGRX,neutral
46379.0,"H.C. Wainwright Maintains Buy on Agile Therapeutics, Raises Price Target to $7",2020-02-18 09:58:00-05:00,AGRX,neutral
46380.0,"RBC Capital Maintains Outperform on Agile Therapeutics, Raises Price Target to $8",2020-02-18 09:20:00-05:00,AGRX,neutral
46381.0,"FDA Approves Agile Therapeutics, Inc.'s Twirla Transdermal System On Friday",2020-02-18 08:58:00-05:00,AGRX,positive
46382.0,35 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-18 08:25:00-05:00,AGRX,neutral
46383.0,30 Stocks Moving in Tuesday's Pre-Market Session,2020-02-18 07:13:00-05:00,AGRX,neutral
46384.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,AGRX,positive
46385.0,"Agile Therapeutics shares are trading lower, not currently seeing company-specific news. NOTE: Co.'s PDUFA date for Twirla is expected for Feb. 16.",2020-02-13 10:25:00-05:00,AGRX,neutral
46386.0,Mid-Morning Market Update: Markets Open Lower; PepsiCo Tops Q4 Views,2020-02-13 10:24:00-05:00,AGRX,positive
46387.0,"Agile Therapeutics Shares Resume Trade, Rebound From Low, Halted On Fourth Circuit Breaker Down 28.7% For Session",2020-02-13 10:19:00-05:00,AGRX,neutral
46388.0,"Agile Therapeutics Shares Down ~33%; Not Seeing News To Justify Sharp Move Lower But Reminder Co. Had PDUFA Date For Twirla Extended To Feb. 16, 2020",2020-02-13 10:17:00-05:00,AGRX,neutral
46389.0,"Agile Therapetuics Shares Remain Halted Following Third Circuit Breaker; First 2 Circuit Breakers Were For 5 Mins, Last Circuit Breaker Has Been Longer Than 5 Mins.; Expect Shares To Resume Trade At 10:17:08 a.m. EST",2020-02-13 10:14:00-05:00,AGRX,positive
46390.0,Agile Therapeutics Shares Halted On Third Circuit Breaker,2020-02-13 10:08:00-05:00,AGRX,positive
46391.0,"Agile Therapeutics Shares Resume Trade, Continue Lower, Now Down 33% For Session",2020-02-13 10:07:00-05:00,AGRX,neutral
46392.0,"Agile Therapeutics Shares Resume Trade, Fall ~26%; Immediately Halted On Circuit Breaker",2020-02-13 10:02:00-05:00,AGRX,positive
46393.0,Agile Therapeutics Shares Halted On Circuit Breaker,2020-02-13 09:56:00-05:00,AGRX,positive
46394.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,AGRX,negative
46395.0,36 Stocks Moving in Thursday's Pre-Market Session,2020-02-13 07:32:00-05:00,AGRX,neutral
46396.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-12 11:45:00-05:00,AGRX,neutral
46397.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,AGRX,positive
46398.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-02-12 07:15:00-05:00,AGRX,neutral
46399.0,Agile Therapeutics shares are trading higher after the company finalized a $35 million term loan credit facility.,2020-02-11 11:57:00-05:00,AGRX,positive
46400.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,AGRX,neutral
46401.0,Agile Finalizes $35M Term Loan Facility As Twirla PDUFA Date Looms,2020-02-11 08:46:00-05:00,AGRX,negative
46402.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,AGRX,positive
46403.0,Agile Therapeutics Reports Entered $35M Loan Facility With Perceptive Advisors,2020-02-10 16:32:00-05:00,AGRX,neutral
46404.0,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,2020-02-03 13:30:00-05:00,AGRX,neutral
46405.0,30 Stocks Moving in Monday's Pre-Market Session,2020-02-03 07:30:00-05:00,AGRX,neutral
46406.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,AGRX,positive
46407.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-29 10:16:00-05:00,AGRX,neutral
46408.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,AGRX,neutral
46409.0,12 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-29 07:41:00-05:00,AGRX,neutral
46410.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-01-29 07:15:00-05:00,AGRX,neutral
46411.0,70 Biggest Movers From Yesterday,2020-01-29 04:40:00-05:00,AGRX,neutral
46412.0,Agile Therapeutics shares are trading higher. Not seeing any company-specific news to justify the price action.,2020-01-28 11:53:00-05:00,AGRX,positive
46413.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-28 11:05:00-05:00,AGRX,neutral
46414.0,70 Biggest Movers From Friday,2020-01-27 04:02:00-05:00,AGRX,neutral
46415.0,44 Stocks Moving In Friday's Mid-Day Session,2020-01-24 12:08:00-05:00,AGRX,neutral
46416.0,Stocks That Hit 52-Week Highs On Friday,2020-01-24 10:41:00-05:00,AGRX,neutral
46417.0,14 Drug Manufacturers—Specialty & Generic Stocks Moving In Thursday's Session,2020-01-23 12:52:00-05:00,AGRX,neutral
46418.0,Traders Circulate Bullish Blog Post On Agile Therapeutics,2020-01-22 14:33:00-05:00,AGRX,neutral
46419.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,AGRX,negative
46420.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,AGRX,neutral
46421.0,65 Biggest Movers From Yesterday,2020-01-03 04:36:00-05:00,AGRX,neutral
46422.0,42 Stocks Moving In Thursday's Mid-Day Session,2020-01-02 12:13:00-05:00,AGRX,neutral
46423.0,38 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-30 08:21:00-05:00,AGRX,neutral
46424.0,25 Stocks Moving in Monday's Pre-Market Session,2019-12-30 07:47:00-05:00,AGRX,neutral
46425.0,33 Stocks Moving In Tuesday's Mid-Day Session,2019-12-24 11:34:00-05:00,AGRX,neutral
46426.0,Mid-Morning Market Update: Markets Mostly Flat; WESCO Confirms Proposal To Purchase Anixter,2019-12-24 10:44:00-05:00,AGRX,neutral
46427.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-20 08:19:00-05:00,AGRX,neutral
46428.0,38 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-09 08:26:00-05:00,AGRX,neutral
46429.0,Agile Therapeutics shares are trading higher. Not seeing any news to justify the price action. NOTE: The company has rallied approximately 28% over the past 5 trading sessions.,2019-11-26 11:34:00-05:00,AGRX,positive
46430.0,Agile Therapeutics shares are trading higher. Not seeing any company-specific news to justify the price action.,2019-11-25 14:01:00-05:00,AGRX,positive
46431.0,"Agile Therapeutics shares are trading higher after Joseph Edelman bought 5.768M shares at an average price of $1.68 per share. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.",2019-11-19 08:45:00-05:00,AGRX,positive
46432.0,66 Biggest Movers From Friday,2019-11-18 05:37:00-05:00,AGRX,neutral
46433.0,41 Stocks Moving In Friday's Mid-Day Session,2019-11-15 12:15:00-05:00,AGRX,neutral
46434.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,AGRX,neutral
46435.0,35 Stocks Moving in Friday's Pre-Market Session,2019-11-15 07:52:00-05:00,AGRX,neutral
46436.0,"Agile Therapeutics shares are trading lower after the company announced that the FDA has extended the Twiria NDA review period from Nov 16, 2019, to Feb 16, 2020.",2019-11-15 07:26:00-05:00,AGRX,neutral
46437.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,AGRX,negative
46438.0,70 Biggest Movers From Yesterday,2019-11-15 05:29:00-05:00,AGRX,neutral
46439.0,"Agile Therapeutics shares are trading lower after the company announced that the FDA extension of the Twiria NDA review period from Nov 16, 2019, to Feb 16, 2020.",2019-11-14 16:46:00-05:00,AGRX,neutral
46440.0,Agile Therapeutics Announces FDA Extension Of Twirla NDA Review Period From Nov. 16 2019 To Feb. 16 2020,2019-11-14 16:34:00-05:00,AGRX,neutral
46441.0,Agile Therapeutics shares are trading higher on seemingly no company-specific news.,2019-11-14 11:14:00-05:00,AGRX,neutral
46442.0,Agile Therapeutics shares are trading lower after the company announced it would file for a $20 million common stock offering.,2019-11-11 08:47:00-05:00,AGRX,neutral
46443.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,AGRX,positive
46444.0,94 Biggest Movers From Yesterday,2019-11-08 06:01:00-05:00,AGRX,neutral
46445.0,75 Stocks Moving In Thursday's Mid-Day Session,2019-11-07 12:19:00-05:00,AGRX,neutral
46446.0,Agile Therapeutics shares are trading lower. Not seeing any news to justify the price action.,2019-11-07 09:20:00-05:00,AGRX,neutral
46447.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-07 08:04:00-05:00,AGRX,neutral
46448.0,30 Stocks Moving in Thursday's Pre-Market Session,2019-11-07 07:58:00-05:00,AGRX,neutral
46449.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,AGRX,negative
46450.0,62 Stocks Moving In Wednesday's Mid-Day Session,2019-11-06 13:48:00-05:00,AGRX,neutral
46451.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-06 10:10:00-05:00,AGRX,neutral
46452.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,AGRX,positive
46453.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-06 07:52:00-05:00,AGRX,neutral
46454.0,28 Stocks Moving in Wednesday's Pre-Market Session,2019-11-06 07:24:00-05:00,AGRX,neutral
46455.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-05 11:12:00-05:00,AGRX,neutral
46456.0,﻿Agile Therapeutics shares are trading higher on continued momentum after the company announced a favorable outcome of the FDA advisory committed meeting for its investigation in transdermal contraceptive patch for the AG200-15.,2019-11-05 08:47:00-05:00,AGRX,positive
46457.0,10 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-11-05 07:33:00-05:00,AGRX,neutral
46458.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,AGRX,negative
46459.0,Stocks That Hit 52-Week Highs On Monday,2019-11-04 14:43:00-05:00,AGRX,neutral
46460.0,﻿Agile Therapeutics shares are trading higher on continued momentum after the company announced a favorable outcome of the FDA advisory committed meeting for its investigation in transdermal contraceptive patch for the AG200-15.,2019-11-04 11:26:00-05:00,AGRX,positive
46461.0,24 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-04 08:13:00-05:00,AGRX,neutral
46462.0,Agile Therapeutics shares are trading higher after the company announced a favorable outcome of the FDA advisory committed meeting for its investigation in transdermal contraceptive patch for the AG200-15.,2019-11-01 11:34:00-04:00,AGRX,positive
46463.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-01 08:21:00-04:00,AGRX,neutral
46464.0,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,2019-11-01 08:05:00-04:00,AGRX,neutral
46465.0,Agile Therapeutics Rallies After FDA Panel Backs Contraceptive Patch,2019-10-31 10:52:00-04:00,AGRX,negative
46466.0,"Benzinga Pro's Top 5 Stocks To Watch For Thurs., Oct. 31, 2019: AAPL, FB, AGRX, X, CROX",2019-10-31 08:34:00-04:00,AGRX,positive
46467.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,AGRX,positive
46468.0,"Agile Therapeutics Shares Resume Trade, Up 264%",2019-10-31 07:11:00-04:00,AGRX,positive
46469.0,Agile Therapeutics Shares To Resume Trade At 7:10 a.m. EDT,2019-10-31 06:58:00-04:00,AGRX,positive
46470.0,"Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15)",2019-10-31 04:23:00-04:00,AGRX,positive
46471.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,AGRX,negative
46472.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-29 10:53:00-04:00,AGRX,negative
46473.0,Agile Therapeutics shares are trading lower ahead of the company's Wednesday meeting with the FDA to discuss its twirla marketing application. Briefing documents have caused investor concerns over the probability of the application being successful.,2019-10-29 10:50:00-04:00,AGRX,positive
46474.0,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-29 08:33:00-04:00,AGRX,neutral
46475.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,AGRX,positive
46476.0,Stocks That Hit 52-Week Lows On Monday,2019-10-28 11:12:00-04:00,AGRX,negative
46477.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-28 08:21:00-04:00,AGRX,neutral
46478.0,Agile Therapeutics Q3 EPS $(0.08) Up From $(0.11) YoY,2019-10-28 08:11:00-04:00,AGRX,neutral
46479.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,AGRX,neutral
46480.0,33 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-23 08:48:00-04:00,AGRX,neutral
46481.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,AGRX,neutral
46482.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-30 08:44:00-04:00,AGRX,neutral
46483.0,82 Biggest Movers From Friday,2019-08-05 05:40:00-04:00,AGRX,neutral
46484.0,60 Stocks Moving In Friday's Mid-Day Session,2019-08-02 13:43:00-04:00,AGRX,neutral
46485.0,Agile Therapeutics shares are trading lower after the company price a 12.63 million share common stock offering at $0.95/share.,2019-08-02 09:43:00-04:00,AGRX,positive
46486.0,Agile Therapeutics Prices 12.63M Common Stock Offering At $0.95/Share,2019-08-02 09:15:00-04:00,AGRX,neutral
46487.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-02 09:07:00-04:00,AGRX,neutral
46488.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,AGRX,neutral
46489.0,Agile Therapeutics Announces Twirla PDUFA Date Of Nov. 16,2019-08-01 08:52:00-04:00,AGRX,neutral
46490.0,Agile Therapeutics Q2 EPS $(0.08) Beats $(0.11) Estimate,2019-08-01 08:51:00-04:00,AGRX,neutral
46491.0,Agile Therapeutics Names Dennis Reilly CFO,2019-07-18 07:34:00-04:00,AGRX,neutral
46492.0,"Oppenheimer Reiterates Buy On Agile Therapeutics, Says 'Updated FDA Guidance Looks Supportive for Twirla'",2019-07-15 14:40:00-04:00,AGRX,positive
46493.0,"Agile Therapeutics Announces FDA Advisory Committee Meeting For Its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla (AG200-15)",2019-06-24 16:17:00-04:00,AGRX,neutral
46494.0,"Benzinga's Top Upgrades, Downgrades For June 7, 2019",2019-06-07 09:05:00-04:00,AGRX,positive
46495.0,"Oppenheimer Initiates Coverage On Agile Therapeutics with Outperform Rating, Announces $5 Price Target",2019-06-07 06:55:00-04:00,AGRX,neutral
46496.0,Agile Therapeutics Reports FDA Acceptance Of New Drug Application For Resubmission Of Twirla,2019-05-22 07:04:00-04:00,AGRX,positive
46497.0,"Benzinga's Top Upgrades, Downgrades For May 21, 2019",2019-05-21 09:16:00-04:00,AGRX,positive
46498.0,"The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering",2019-05-17 08:03:00-04:00,AGRX,neutral
46499.0,"Agile Therapeutics Reports Resubmission Of New Drug Application For Its Transdermal Low-Dose Contraceptive Patch, Twirla",2019-05-17 07:30:00-04:00,AGRX,neutral
46500.0,Agile Therapeutics Will Present Combined Safety Data From 3 Phase 3 Studies At ACOG Meeting,2019-05-03 08:07:00-04:00,AGRX,positive
46501.0,"Agile Therapeutics, Inc. Q1 EPS $(0.13) Misses $(0.1) Estimate",2019-05-02 18:01:00-04:00,AGRX,negative
46502.0,"Agile Therapeutics, Inc. Q4 EPS $(0.11) Beats $(0.15) Estimate",2019-03-12 16:17:00-04:00,AGRX,neutral
46503.0,Agile Therapeutics shares are trading higher after the company announced a $7.8 million private placement of 8.4 million shares with Perceptive Advisors.,2019-03-04 12:26:00-05:00,AGRX,positive
46504.0,Agile Therapeutics Announces $7.8M Private Placement,2019-03-04 07:33:00-05:00,AGRX,neutral
46505.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Feb. 11, 2019",2019-02-11 15:57:00-05:00,AGRX,positive
46506.0,35 Stocks Moving In Monday's Mid-Day Session,2019-02-11 12:27:00-05:00,AGRX,neutral
46507.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Monday, February 11, 2019",2019-02-11 09:44:00-05:00,AGRX,positive
46508.0,Agile Therapeutics shares are trading higher after the company announced that Twirla met its primary endpoint.,2019-02-11 09:26:00-05:00,AGRX,positive
46509.0,Agile Therapeutics shares are trading higher after the company announced that its Twirla product met its primary endpoint for adhesion strength.,2019-02-11 09:25:00-05:00,AGRX,positive
46510.0,26 Stocks Moving In Monday's Pre-Market Session,2019-02-11 07:38:00-05:00,AGRX,neutral
46511.0,Agile Therapeutics' Twirla Met its Primary Endpoint,2019-02-11 07:31:00-05:00,AGRX,neutral
46512.0,"The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA",2019-01-11 08:38:00-05:00,AGRX,negative
46513.0,Agile Therapeutics Says Cash Enables Co. To Fund Operations Into Q2'19,2019-01-10 16:17:00-05:00,AGRX,neutral
46514.0,"Agile Therapeutics Says Discussions With FDA On Design Of Comparative Wear Study Of Twirla, Xulane Completed",2019-01-10 16:17:00-05:00,AGRX,neutral
46515.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,AGRX,neutral
46516.0,"Agile Therapeutics shares down 1.5% following an update on the company's comparative wear study of Twirla, Xulane following a meeting with the FDA",2018-12-13 17:41:00-05:00,AGRX,positive
46517.0,"UPDATE: Agile Sees Completing Twirla, Xulane Study In Q1'19, Resubmitting Twirla New Drug Application In 1H'19",2018-12-13 17:40:00-05:00,AGRX,neutral
46518.0,"UPDATE: Agile Therapeutics Sees Conducting Crossover Wear Study In Healthy Women With Body Mass Index Less Than 35 kg/m2 Using Either Twirla, Xulane",2018-12-13 17:39:00-05:00,AGRX,positive
46519.0,"Agile Therapeutics, Inc. Meets With FDA On Comparative Wear Study Of Twirla And Xulane",2018-12-13 16:19:00-05:00,AGRX,neutral
46520.0,"Maxim Group Initiates Coverage On Agile Therapeutics with Buy Rating, Announces $3 Price Target",2018-11-29 09:34:00-05:00,AGRX,neutral
46521.0,"Agile Therapeutics, Inc. - Common Stock Q3 EPS $(0.11) Beats $(0.17) Estimate",2018-11-01 16:18:00-04:00,AGRX,neutral
46522.0,Agile Therapeutics Shares Up 15% On Heavy Volume (~92K Shares) Premarket; Co. Issued Press Release Highlighting Presentation Of Data From Phase 3 SECURE Study Of AG200-15 At North American Forum on Family Planning; No New Details Included In Release,2018-10-24 08:40:00-04:00,AGRX,positive
46523.0,"10 Hottest Stocks From October 16, 2018",2018-10-16 16:33:00-04:00,AGRX,neutral
46524.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Oct. 16, 2018",2018-10-16 15:36:00-04:00,AGRX,positive
46525.0,"10 Hottest Stocks From October 15, 2018",2018-10-15 17:26:00-04:00,AGRX,neutral
46526.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 15, 2018",2018-10-15 16:35:00-04:00,AGRX,positive
46527.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Oct. 10, 2018",2018-10-10 11:07:00-04:00,AGRX,positive
46528.0,46 Biggest Movers From Yesterday,2018-10-10 05:08:00-04:00,AGRX,neutral
46529.0,"10 Hottest Stocks From October 9, 2018",2018-10-09 17:47:00-04:00,AGRX,neutral
46530.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Oct. 9, 2018",2018-10-09 16:27:00-04:00,AGRX,positive
46531.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Affimed Shares Plunge,2018-10-09 14:33:00-04:00,AGRX,negative
46532.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-10-09 12:39:00-04:00,AGRX,neutral
46533.0,Mid-Day Market Update: Blackbaud Drops On Lowered FY18 Outlook; Agile Therapeutics Shares Surge,2018-10-09 12:06:00-04:00,AGRX,positive
46534.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,AGRX,positive
46535.0,Mid-Morning Market Update: Markets Mostly Lower; Helen of Troy Beats Q2 Estimates,2018-10-09 10:15:00-04:00,AGRX,negative
46536.0,Agile Therapeutics shares are up 55.9% premarket after the company completed a formal dispute resolution process with the FDA.,2018-10-09 08:57:00-04:00,AGRX,negative
46537.0,"Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process With The FDA; FDA's Office Of New Drugs Suggested Co. Conduct A Wear Study To Evaluate Whether Twirla Demonstrates A Similar Adhesion Performance To Xulane",2018-10-09 08:04:00-04:00,AGRX,negative
46538.0,48 Biggest Movers From Yesterday,2018-09-12 05:20:00-04:00,AGRX,neutral
46539.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-09-11 12:31:00-04:00,AGRX,neutral
46540.0,"UPDATE: 1 Trader Earlier Highlighted Agile Therapeutics As A Possible Sympathy Play Given Mon. Momentum In Another Penny Stock, Netlist",2018-09-11 09:31:00-04:00,AGRX,positive
46541.0,Agile Therapeutics Shares Indicated Up 97% Premarket On Very Heavy Volume; Stock Has Traded Nearly 1.6M Shares Premarket vs Normal Full-Day Volume Of ~518K Shares,2018-09-11 09:27:00-04:00,AGRX,positive
46542.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,AGRX,neutral
46543.0,"Stocks Which Set New 52-Week Low Yesterday, August 9th",2018-08-10 10:05:00-04:00,AGRX,negative
46544.0,"Stocks Which Set New 52-Week Low Yesterday, August 2nd",2018-08-03 11:22:00-04:00,AGRX,negative
46545.0,"Agile Therapeutics, Inc. - Common Stock Q2 EPS $(0.16) Beats $(0.17) Estimate",2018-08-03 08:02:00-04:00,AGRX,neutral
46546.0,"Stocks Which Set New 52-Week Low Yesterday, July 25th",2018-07-26 11:19:00-04:00,AGRX,negative
46547.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,AGRX,negative
46548.0,50 Biggest Movers From Yesterday,2018-07-26 04:16:00-04:00,AGRX,neutral
46549.0,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Travelzoo Shares Slide,2018-07-25 14:56:00-04:00,AGRX,positive
46550.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-07-25 12:50:00-04:00,AGRX,neutral
46551.0,Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Plunge,2018-07-25 12:21:00-04:00,AGRX,negative
46552.0,"Shares Of Penny Stock Agile Therapeutics Fall ~18% Over Last Min., Rebound At $0.30 Level; Not Seeing News To Justify Move Lower",2018-07-25 10:16:00-04:00,AGRX,neutral
46553.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,AGRX,positive
46554.0,Agile Therapeutics Shares Down 41% After FDA Denied Co.'s Appeal In Relation To NDA For Co.'s Twirla,2018-07-24 17:11:00-04:00,AGRX,negative
46555.0,UPDATE: Agile Therapeutics Reports Planning To Appeal FDA's Office Of New Drugs,2018-07-24 16:11:00-04:00,AGRX,neutral
46556.0,"Agile Therapeutics Reports Office Director Of FDA's Office Of Drug Evaluation III Affirmed Position Of Division Of Bone, Reproductive, Urologic Products, Denied Co.'s Appeal Of Dec. 21, 2017 CRL Related To NDA For Twirla",2018-07-24 16:11:00-04:00,AGRX,negative
46557.0,Stocks Which Set New 52-Week Lows Friday,2018-07-23 11:11:00-04:00,AGRX,negative
46558.0,"Benzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium",2018-07-03 07:51:00-04:00,AGRX,neutral
46559.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,AGRX,positive
46560.0,"UPDATE: Agile Therapeutics Reports Headcount Reductions, Expenses Expected To Allow Existing Cash To Fund Operations Into Q2'19",2018-06-07 16:13:00-04:00,AGRX,positive
46561.0,Agile Therapeutics To Cut Headcount By ~30%; Reports Formal Dispute Resolution Request Was Submitted To FDA Related To Twirla,2018-06-07 16:12:00-04:00,AGRX,negative
46562.0,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",2018-05-30 08:14:00-04:00,AGRX,positive
46563.0,36 Biggest Movers From Friday,2018-05-21 04:54:00-04:00,AGRX,neutral
46564.0,"Benzinga's Biggest Movers For The Week Of May 14, 2018",2018-05-18 16:00:00-04:00,AGRX,neutral
46565.0,Mid-Afternoon Market Update: Applied Materials Falls On Weak Sales Forecast; Quotient Shares Spike Higher,2018-05-18 14:31:00-04:00,AGRX,negative
46566.0,26 Stocks Moving In Friday's Mid-Day Session,2018-05-18 12:27:00-04:00,AGRX,neutral
46567.0,Mid-Day Market Update: Shineco Rises After Q3 Results; Campbell Soup Shares Slide,2018-05-18 12:06:00-04:00,AGRX,positive
46568.0,Mid-Morning Market Update: Markets Mixed; Deere Misses Q2 Estimates,2018-05-18 10:24:00-04:00,AGRX,negative
46569.0,Agile Therapeutics Shares Down 70.8% Premarket After FDA Announced Significant Concerns Regarding The Adhesion Of Twirla; Co. Is Re-Evaluating Plans To Identify Ways To Fund Co. Ops,2018-05-18 09:18:00-04:00,AGRX,positive
46570.0,"Agile Therapeutics Says FDA Has Significant Concerns Regarding The Adhesion Of Twirla Which Believes The Co. Cannot Address Through Proposed Patient Compliance Programs; Due To FDA Feedback, The Co. Is Re-Evaluating Plans To Identify Ways To Fund Co. Ops",2018-05-18 07:32:00-04:00,AGRX,positive
46571.0,"Agile Therapeutics, Inc. - Common Stock Q1 EPS $(0.20), Inline",2018-05-07 16:38:00-04:00,AGRX,neutral
46572.0,Agile Therapeutics Reports AG200-15 (Twirla) Abstract Accepted For Presentation At APhA Meeting,2018-03-14 07:46:00-04:00,AGRX,positive
46573.0,Agile Therapeutics Reports Q4 EPS $(0.18) vs $(0.24) Est.,2018-03-12 16:19:00-04:00,AGRX,neutral
46574.0,"13F From Perceptive Advisors Late Wednesday Shows Increased Stake In Abiomed, Neurocrine Biosciences, VBI Vaccines; New Stake In Agile Therapeutics, Amgen, bluebird bio, Arena Pharma, Revance Therapeutics; Exited Stake In Achaogen, OraSure Technologies",2018-02-15 10:41:00-05:00,AGRX,positive
46575.0,"13G Filing Shows Perceptive Advisors Reporting New 9.9% Stake In Agile Therapeutics, Shares Spike To High Of $3.03, Up 7.83%",2018-01-09 12:37:00-05:00,AGRX,positive
46576.0,Analyst Remains Confident In Corium Despite Partner's Bad FDA News,2017-12-27 11:19:00-05:00,AGRX,positive
46577.0,32 Biggest Movers From Yesterday,2017-12-27 04:59:00-05:00,AGRX,neutral
46578.0,Agile Therapeutics Shares Continue Rebound From $1.04 Pre-Market Low Fri.; Move Comes Despite 2 Downgrades Tues. Morn.; Stock Fell ~60% At Open Fri. Following News Of CRL From FDA For Twirla NDA; Shares Have Rebounded By ~176% Since Fri. Low,2017-12-26 15:29:00-05:00,AGRX,positive
46579.0,30 Stocks Moving In Tuesday's Mid-Day Session,2017-12-26 14:20:00-05:00,AGRX,neutral
46580.0,5 Biggest Price Target Changes For Tuesday,2017-12-26 09:42:00-05:00,AGRX,neutral
46581.0,"Benzinga's Top Upgrades, Downgrades For December 26, 2017",2017-12-26 09:06:00-05:00,AGRX,positive
46582.0,A Peek Into The Markets: U.S. Stock Futures Down; Mallinckrodt To Acquire Sucampo Pharmaceuticals,2017-12-26 07:10:00-05:00,AGRX,neutral
46583.0,44 Biggest Movers From Friday,2017-12-26 05:09:00-05:00,AGRX,neutral
46584.0,Mid-Afternoon Market Update: Dow Falls Over 50 Points; SMART Global Shares Spike Higher,2017-12-22 14:30:00-05:00,AGRX,positive
46585.0,36 Stocks Moving In Friday's Mid-Day Session,2017-12-22 12:33:00-05:00,AGRX,neutral
46586.0,Mid-Day Market Update: Ignyta Surges Following Merger Deal With Roche; Agile Therapeutics Shares Plunge,2017-12-22 12:16:00-05:00,AGRX,positive
46587.0,"Agile Therapeutics Shares Down 51.47%; Earlier Co. Announced Receipt Of CRL From FDA For Twirla NDA, FDA Says It Cannot Approve the NDA 'In its present form.'",2017-12-22 11:16:00-05:00,AGRX,positive
46588.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2017-11-30 08:34:00-05:00,AGRX,neutral
46589.0,Corium Q4 Sales Top Expectations Ahead Of Slew Of Near-Term Catalysts,2017-11-17 09:13:00-05:00,AGRX,positive
46590.0,Agile Therapeutics Reports Q3 EPS $(0.22) vs $(0.24) Est.,2017-11-06 16:22:00-05:00,AGRX,neutral
46591.0,Agile Therapeutics Shows Added Phase 3 SECURE Trial Results For Twirla: Suggests May Decrease Mean Length of Bleeding and Spotting Episodes,2017-10-31 08:21:00-04:00,AGRX,positive
46592.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-10-12 08:03:00-04:00,AGRX,neutral
46593.0,"Watching Flexion, AxelRx, Agile Therapeutics Shares Premarket Thurs. Following Reuters Highlighting 'RBC sees 3 small-cap drugmakers as candidates for takeover'; Stocks Not Moving",2017-10-05 07:20:00-04:00,AGRX,positive
46594.0,"H.C. Wainwright Assumes Agile Therapeutics at Buy, Announces price target $10.00",2017-10-02 08:30:00-04:00,AGRX,neutral
46595.0,25 Biggest Mid-Day Losers For Thursday,2017-08-03 13:02:00-04:00,AGRX,negative
46596.0,Mid-Morning Market Update: Markets Mostly Lower; Kellogg Beats Q2 Expectations,2017-08-03 10:17:00-04:00,AGRX,negative
46597.0,Agile Therapeutics Shares Down 22% Pre-Market After 5.33M Share Offering Priced At $3.75/Share,2017-08-03 09:14:00-04:00,AGRX,positive
46598.0,Agile Therapeutics Prices Offering Of 5.33M Shares At $3.75/Share,2017-08-03 08:25:00-04:00,AGRX,positive
46599.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-08-03 08:07:00-04:00,AGRX,neutral
46600.0,"Agile Therapeutics Reports Offering Of Common Shares, Amount Not Disclosed",2017-08-02 17:52:00-04:00,AGRX,positive
46601.0,Agile Therapeutics Flat Premarket; Friday Morning Co. Reported Q2 EPS $(0.26) vs $(0.28) Est.,2017-07-31 08:21:00-04:00,AGRX,neutral
46602.0,Agile Therapeutics Announces FDA Accepts NDA Resubmission of Twirla,2017-07-27 16:13:00-04:00,AGRX,positive
46603.0,18 Biggest Mid-Day Gainers For Wednesday,2017-07-19 12:22:00-04:00,AGRX,neutral
46604.0,"Benzinga's Top Upgrades, Downgrades For July 19, 2017",2017-07-19 09:25:00-04:00,AGRX,positive
46605.0,"H.C. Wainwright Initiates Coverage On Agile Therapeutics with Buy Rating, Announces $10.00 Price Target",2017-07-19 07:06:00-04:00,AGRX,neutral
46606.0,Agile Therapeutics Resubmits New Drug Application For Twirla,2017-06-27 08:04:00-04:00,AGRX,neutral
46607.0,22 Stocks Moving In Friday's Pre-Market Session,2017-06-16 08:28:00-04:00,AGRX,neutral
46608.0,"Companies Holding Shareholder Meetings Today Include: Aerie Pharma, Agile Therapeutics, bluebird bio, Bojangles, Comcast, Clovis Oncology, Etsy, Egalet, Dave And Busters, Ingersoll-Rand, Priceline, Lululemon, Rent-A-Center, Splunk, & Zoe's Kitchen",2017-06-08 09:41:00-04:00,AGRX,neutral
46609.0,Corium Hopes Stock Offering Will Firm Its Footing In Pharma Partner Talks,2017-05-25 11:16:00-04:00,AGRX,positive
46610.0,"Corium Spokesperson, Regarding Stock Offering, Tells Benzinga It Gives Co. Leverage In Partnering Discussions, Which Remain 'Very Active'; Also Helps Prepare For Potential Approval Of Agile's Twirla NDA, For Which Corium Is Exclusive Supplier",2017-05-25 11:14:00-04:00,AGRX,positive
46611.0,"CEO Of Corium, Exclusive Supplier Of Twirla To Agile Therapeutics, Tells Benzinga: 'My own personal sense is [Agile] should have an approvable product'",2017-05-18 16:00:00-04:00,AGRX,positive
46612.0,Agile Therapeutics Spikes to High of $3.90 on Volume,2017-05-11 14:26:00-04:00,AGRX,neutral
46613.0,Agile Therapeutics Reports Q1 EPS $(0.26) vs $(0.30) Est.,2017-05-08 16:12:00-04:00,AGRX,neutral
46614.0,Agile Therapeutics Announces New Phase 3 SECURE Study Results Relating to Twirla at ACOG 2017,2017-05-06 15:34:00-04:00,AGRX,positive
46615.0,Volume Spike in Agile Therapeutics,2017-04-25 11:12:00-04:00,AGRX,neutral
46616.0,Agile Therapeutics Confirms Plans to Re-submit New Drug Application for Twirla by the end of the Second Quarter of 2017,2017-04-11 07:05:00-04:00,AGRX,neutral
46617.0,15 Biggest Mid-Day Losers For Monday,2017-03-20 13:09:00-04:00,AGRX,negative
46618.0,22 Stocks Moving In Monday's Pre-Market Session,2017-03-20 08:16:00-04:00,AGRX,neutral
46619.0,15 Biggest Mid-Day Gainers For Friday,2017-03-17 12:29:00-04:00,AGRX,neutral
46620.0,Agile Therapeutics Reports Q4 EPS $(0.18) vs. $(0.28) Est.,2017-03-08 16:19:00-05:00,AGRX,neutral
46621.0,"RBC Capital Markets Healthcare Conference Concludes Today; Presenters Include Spark Therapeutics, Johnson & Johnson, HCA Holdings, Ocular Therapeutix, Valeant & Agile Therapeutics",2017-02-23 08:04:00-05:00,AGRX,positive
46622.0,"Bio CEO & Investor Conference Begins Today; Presenters Include Inovio Pharmaceuticals, Agile Therapeutics, CytRx, Eiger Biopharmaceuticals, Neurotrope, & Ocular Therapeutix",2017-02-13 08:36:00-05:00,AGRX,neutral
46623.0,Mid-Afternoon Market Update: NASDAQ Gains Over 50 Points; Evoke Pharma Shares Spike Higher,2017-01-04 14:41:00-05:00,AGRX,positive
46624.0,10 Biggest Mid-Day Losers For Wednesday,2017-01-04 12:54:00-05:00,AGRX,negative
46625.0,Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Slide,2017-01-04 12:13:00-05:00,AGRX,negative
46626.0,Agile Therapeutics Craters 40%,2017-01-04 11:23:00-05:00,AGRX,neutral
46627.0,Mid-Morning Market Update: Markets Open Higher; UniFirst Posts Lower Q1 Profit,2017-01-04 10:08:00-05:00,AGRX,positive
46628.0,15 Stocks Moving In Wednesday's Pre-Market Session,2017-01-04 08:20:00-05:00,AGRX,neutral
46629.0,"Agile Therapeutics Shares Resume Trade, Now Down 60%",2017-01-03 16:41:00-05:00,AGRX,positive
46630.0,Agile Therapeutics Shares to Resume Trade at 4:45 p.m. EST,2017-01-03 16:36:00-05:00,AGRX,positive
46631.0,UPDATE: Agile Therapeutics Says SECURE Study Population Representative of Population of Women in US with Respect to Key Demographic Criteria,2017-01-03 16:14:00-05:00,AGRX,positive
46632.0,Agile Therapeutics Says resubmission of Twirla NDA Expected to Address FDA's CRL; Co. Plans to Resubmit NDA in 1H'17,2017-01-03 16:12:00-05:00,AGRX,neutral
46633.0,Agile Therapeutics Shares Halted News Pending,2017-01-03 16:05:00-05:00,AGRX,positive
46634.0,Agile Therapeutics Announces $3M of Financing From State of New Jersey Program,2016-12-01 08:05:00-05:00,AGRX,neutral
46635.0,Agile Therapeutics Reports Q3 EPS $(0.27) vs $(0.35) Est.,2016-11-07 16:35:00-05:00,AGRX,neutral
46636.0,"Agile Therapeutics, On Oct. 5th, Appointed CEO Al Altomari Chairman Of The Board Effective Immediately",2016-10-06 17:16:00-04:00,AGRX,positive
46637.0,Agile Therapeutics Reports Q2 EPS $(0.29) vs. Est. $(0.29),2016-08-08 16:51:00-04:00,AGRX,neutral
46638.0,Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline  Initial Phase 2 Trial Of A Novel Contraceptive Regimen,2016-07-12 16:12:00-04:00,AGRX,positive
46639.0,Agile Therapeutics Names Renee Selman Chief Commercial Officer,2016-07-06 16:18:00-04:00,AGRX,neutral
46640.0,Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs,2016-06-16 08:00:00-04:00,AGRX,neutral
46641.0,Agile Therapeutics Q1 EPS ($0.27) vs ($0.38) est,2016-05-09 17:08:00-04:00,AGRX,neutral
46642.0,Agile Therapeutics Reports Q4 EPS $(0.17) vs. Est. $(0.36),2016-03-09 16:10:00-05:00,AGRX,neutral
46643.0,Agile Therapeutics Plunges After Company Prices A Stock Offering At $6.35 Per Share,2016-01-22 13:39:00-05:00,AGRX,positive
46644.0,Mid-Day Market Update: Crude Oil Jumps 7%; Golar LNG Shares Gain on News of MoU with Schlumberger,2016-01-22 11:52:00-05:00,AGRX,positive
46645.0,Mid-Morning Market Update: Markets Open Higher; General Electric Profit Beats Views,2016-01-22 10:05:00-05:00,AGRX,positive
46646.0,Agile Therapeutics Prices 5.511M Shares At $6.35/Share,2016-01-22 09:17:00-05:00,AGRX,positive
46647.0,Agile Therapeutics Announces Proposed Offering of $30M Worth Of Common Stock,2016-01-21 16:08:00-05:00,AGRX,positive
46648.0,Eagle Pharma and AMRI Announces Joint Development of Parental Drugs,2016-01-11 06:51:00-05:00,AGRX,neutral
46649.0,Benzinga's Top Initiations,2016-01-08 09:37:00-05:00,AGRX,positive
46650.0,Cantor Initiates Coverage on Agile Therapeutics at Buy,2016-01-08 08:11:00-05:00,AGRX,neutral
46651.0,Shares of Agile Therapeutics Up 12+% After $9 Resistance Level Taken Out; Stock Currently Flirting with $10 Area,2015-12-30 12:54:00-05:00,AGRX,positive
46652.0,Benzinga's Top Initiations,2015-12-30 10:02:00-05:00,AGRX,positive
46653.0,"Noble Financial  Initiates Coverage on Agile Therapeutics at Buy, Announces $16.00 PT",2015-12-30 09:16:00-05:00,AGRX,positive
46654.0,Agile Therapeutics Reports Inline Q3 EPS ($0.42),2015-11-09 16:57:00-05:00,AGRX,neutral
46655.0,Agile Therapeutics Announces Completion of Patient Enrollment in Twirla Phase 3 SECURE Clinical Trial,2015-10-19 16:09:00-04:00,AGRX,positive
46656.0,Agile Therapeutics Reports Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial,2015-08-31 16:07:00-04:00,AGRX,positive
46657.0,Agile Therapeutics Reports Q2 EPS $(0.38) vs. Est. $(0.37),2015-08-13 16:07:00-04:00,AGRX,neutral
46658.0,Agile Therapeutics Reports Allowance of Several Patents on Novel Dosing Regimens for Its Pipeline of Follow-On Contraceptive Products,2015-07-23 16:11:00-04:00,AGRX,positive
46659.0,S-3 from Agile Therapeutics Shows Registration for $150M Mixed Securities Shelf Offering,2015-06-19 17:10:00-04:00,AGRX,positive
46660.0,Agile Therapeutics Reports Issuance of Patent for Twirla Patch Design,2015-06-12 07:45:00-04:00,AGRX,neutral
46661.0,Agile Therapeutics Reports Q1 Loss $0.40 vs Est Loss $0.34,2015-05-12 16:27:00-04:00,AGRX,negative
46662.0,Agile Therapeutics Reports Q1 EPS $(0.40) vs. Est. $(0.34),2015-05-12 16:13:00-04:00,AGRX,neutral
46663.0,Benzinga's Top #PreMarket Gainers,2015-04-14 08:23:00-04:00,AGRX,positive
46664.0,"FBR Capital Initiates Coverage on Agile Therapeutics at Outperform, Announces $17.00 PT",2015-04-02 06:20:00-04:00,AGRX,neutral
46665.0,Agile Therapeutics Reports Q4 EPS -$0.37 Vs Est -$0.43,2015-03-26 16:15:00-04:00,AGRX,neutral
46666.0,Amended 13D: Proquest Investments Reports 23.4% Stake In Agile Therapeutics Up From 20.74% Stake From May 13D,2015-01-23 16:55:00-05:00,AGRX,neutral
46667.0,Agile Therapeutics Announces $20M Private Placement And Provides Clinical Trial Update,2015-01-20 07:29:00-05:00,AGRX,neutral
46668.0,"Agile Therapeutics Enters $20M Private Placement, Provides Clinical Trial Update",2015-01-20 07:22:00-05:00,AGRX,neutral
46669.0,"Agile Therapeutics CEO Altomari Acquires 30,000 Shares @$1.76/Share -Form 4",2014-12-22 08:35:00-05:00,AGRX,positive
46670.0,Agile Therapeutics Announces Publication of Data On Low-Dose Investigational Contraceptive Patch,2014-12-01 16:08:00-05:00,AGRX,neutral
46671.0,"Agile Therapeutics Appoints John Hubbard, Ph.D., FCP To Its Board of Directors",2014-11-18 16:06:00-05:00,AGRX,neutral
46672.0,UPDATE: Agile Initiates Phase 3 SECURE Study for Twirla,2014-09-16 08:00:00-04:00,AGRX,positive
46673.0,Agile Initiates Phase 3 SECURE Study for Twirla ,2014-09-16 07:59:00-04:00,AGRX,positive
46674.0,Agile Therapeutics Q2 EPS -$0.28,2014-08-14 16:08:00-04:00,AGRX,neutral
46675.0,"Agile Therapeutics Reports Allowance of Added Patent Claims for SkinFusion, Expecting to Submit Info to FDA for Orange Book Inclusion",2014-07-17 16:45:00-04:00,AGRX,neutral
46676.0,"Mid-Day Market Movers For Monday, June 23, 2014",2014-06-23 15:43:00-04:00,AGRX,neutral
46677.0,UPDATE: Agile Therapeutics Announces New Patents For Skinfusion,2014-06-20 07:33:00-04:00,AGRX,neutral
46678.0,Agile Therapeutics Announces New Patents For Skinfusion,2014-06-20 07:30:00-04:00,AGRX,neutral
46679.0,Morning Market Movers ,2014-06-17 09:45:00-04:00,AGRX,neutral
46680.0,"RBC Capital Initiates Coverage on Agile Therapeutics at Outperform, Announces $12.00 PT",2014-06-17 06:51:00-04:00,AGRX,neutral
46681.0,"Janney Capital Initiates Coverage on Agile Therapeutics at Buy, Announces $18.00 PT",2014-06-17 06:51:00-04:00,AGRX,neutral
46682.0,William Blair Initiates Coverage on Agile Therapeutics at Outperform,2014-06-17 06:51:00-04:00,AGRX,neutral
46683.0,"Cantor Fitzgerald Initiates Coverage on Agile Therapeutics at Buy, Announces $17.00 PT",2014-06-17 06:50:00-04:00,AGRX,neutral
46684.0,"Agile Therapeutics Shareholder Moorin Buys 1,120,833 Shares @$6.00/Share -Form 4",2014-06-02 17:19:00-04:00,AGRX,positive
46685.0,"IPO Recap: S&P Ends Week Up, IPOs End Higher",2014-05-27 11:33:00-04:00,AGRX,neutral
46686.0,"Shares of Agile Therapeutics Open for Trade at $5.50/Share, IPO Priced at $6",2014-05-23 11:01:00-04:00,AGRX,positive
46687.0,Waiting on 3 IPOs This Morning,2014-05-23 09:09:00-04:00,AGRX,neutral
46688.0,Agile Therapeutics 9.17M Share IPO Priced at $6.00/Share ,2014-05-22 09:09:00-04:00,AGRX,positive
46689.0,Waiting on 5 IPOs This Morning,2014-05-22 08:41:00-04:00,AGRX,neutral
46690.0,Agile Therapeutics Expects 4.6M Share IPO to Price $12-$14/Share,2014-05-09 06:43:00-04:00,AGRX,positive
46691.0,Agile Therapeutics Files for Up to $69M IPO -Filing,2014-03-17 16:13:00-04:00,AGRX,neutral
